Abstract
Reactive oxygen species (ROS)‐mediated activation of inflammasome is involved in the development of a wide spectrum of diseases. We aimed to investigate whether (−)schisandrin B [(−)Sch B], a phytochemical that can induce cellular antioxidant response, can suppress the inflammasome activation. Results showed that (−)Sch B can induce an nuclear factor erythroid 2‐related factor 2‐driven thioredoxin expression in primary peritoneal macrophages and cultured RAW264.7 macrophages. A 4‐h priming of peritoneal macrophages with LPS followed by a 30‐min incubation with ATP caused the activation of caspase 1 and the release of IL‐1β, indicative of inflammasome activation. Although LPS/ATP did not activate inflammasome in RAW264.7 macrophages, it caused the ROS‐dependent c‐Jun N‐terminal kinase1/2 (JNK1/2) activation and an associated lactate dehydrogenase (LDH) release in RAW264.7 macrophages, an indication of cytotoxicity. (−)Sch B suppressed the LPS/ATP‐induced activation of caspase 1 and release of IL‐1β in peritoneal macrophages. (−)Sch B also attenuated the LPS/ATP‐induced ROS production, JNK1/2 activation and LDH release in RAW264.7 macrophages. The ability of (−)Sch B to suppress LPS/ATP‐mediated inflammation in vitro was further confirmed by an animal study, in which schisandrin B treatment (2 mmol/kg p.o.) ameliorated the Imject Alum‐induced peritonitis, as indicated by suppressions of caspase1 activation and plasma IL‐1β level. The ensemble of results suggests that (−)Sch B may offer a promising prospect for preventing the inflammasome‐mediated disorders. © 2015 BioFactors, 41(5):314–323, 2015
Funding Information
  • GRF grant (661113)

This publication has 29 references indexed in Scilit: